148 related articles for article (PubMed ID: 38307701)
1. Exploring conservative management for cervical intraepithelial neoplasia grade 2 in organised cervical cancer screening programmes: a multicentre study in Italy.
Gori S; Frayle H; Pagan A; Soldà M; Romagnolo C; Insacco E; Laurino L; Matteucci M; Sordi G; Busato E; Zorzi M; Maggino T; Del Mistro A;
Fam Med Community Health; 2024 Feb; 12(Suppl 2):. PubMed ID: 38307701
[TBL] [Abstract][Full Text] [Related]
2. Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study.
Skorstengaard M; Lynge E; Suhr J; Napolitano G
BJOG; 2020 May; 127(6):729-736. PubMed ID: 31880054
[TBL] [Abstract][Full Text] [Related]
3. Conservative management of CIN2: National Audit of British Society for Colposcopy and Cervical Pathology members' opinion.
Macdonald M; Smith JHF; Tidy JA; Palmer JE
J Obstet Gynaecol; 2018 Apr; 38(3):388-394. PubMed ID: 29212399
[TBL] [Abstract][Full Text] [Related]
4. Role of Chlamydia trachomatis serology in conservative management of cervical intraepithelial neoplasia grade 2.
Miralpeix E; Solé-Sedeño JM; Agramunt S; Lloveras B; Gimeno R; Alameda F; Carreras R; Mancebo G
Int J Gynaecol Obstet; 2019 Oct; 147(1):43-48. PubMed ID: 31272132
[TBL] [Abstract][Full Text] [Related]
5. The 5-year risk of recurrence of grade 2/3 cervical intraepithelial neoplasia after treatment in a population screening programme by human papillomavirus status: A cohort study in central Italy.
Visioli CB; Iossa A; Gorini G; Mantellini P; Lelli L; Auzzi N; Pierro CD; Carozzi FM; Zappa M
J Med Screen; 2023 Dec; 30(4):191-200. PubMed ID: 37229655
[TBL] [Abstract][Full Text] [Related]
6. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
7. Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: A cohort study.
Godfrey MAL; Nikolopoulos M; Garner JE; Adib TR; Mukhopadhyay D; Rains JS; Harper CA; Wuntakal R
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():267-273. PubMed ID: 30048921
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
9. Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping.
Salvadó A; Miralpeix E; Solé-Sedeno JM; Kanjou N; Lloveras B; Duran X; Mancebo G
Gynecol Oncol; 2021 Sep; 162(3):569-574. PubMed ID: 34226019
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21-39 Years.
Silver MI; Gage JC; Schiffman M; Fetterman B; Poitras NE; Lorey T; Cheung LC; Katki HA; Locke A; Kinney WK; Castle PE
Cancer Prev Res (Phila); 2018 Mar; 11(3):165-170. PubMed ID: 29437696
[TBL] [Abstract][Full Text] [Related]
11. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
12. Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years.
Sykes PH; Simcock BJ; Innes CR; Harker D; Williman JA; Whitehead M; van der Griend RA; Lawton BA; Hibma M; Fitzgerald P; Dudley NM; Petrich S; Eva L; Bergzoll C; Kathuria J; McPherson G; Tristram A; Faherty J; Hardie D; Robertson A; Robertson V; Pather S; Wrede CD; Gastrell F; Fentiman G; John M; White E; Parker C; Sadler L
Am J Obstet Gynecol; 2022 Feb; 226(2):222.e1-222.e13. PubMed ID: 34534506
[TBL] [Abstract][Full Text] [Related]
13. "I feel reassured, but there is no guarantee." How do women with a future childbearing desire respond to active surveillance of cervical intraepithelial neoplasia grade 2? A qualitative study.
Hansen J; Kirkegaard P; Folmann B; Bungum HF; Hammer A
Acta Obstet Gynecol Scand; 2022 Jun; 101(6):616-623. PubMed ID: 35383881
[TBL] [Abstract][Full Text] [Related]
14. Active surveillance as a management option for cervical intraepithelial neoplasia 2: An online experimental study.
Dodd RH; Cvejic E; Bell K; Black K; Bateson D; Smith MA; Mac OA; McCaffery KJ
Gynecol Oncol; 2021 Apr; 161(1):179-187. PubMed ID: 33516531
[TBL] [Abstract][Full Text] [Related]
15. Risk of cervical precancer among HPV-negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study.
Inturrisi F; Rozendaal L; Veldhuijzen NJ; Heideman DAM; Meijer CJLM; Berkhof J
PLoS Med; 2022 Oct; 19(10):e1004115. PubMed ID: 36306283
[TBL] [Abstract][Full Text] [Related]
16. [Cervical cancer screening in Italy: quality of colposcopy and treatment. 2010 activity].
Volante R; Giubilato P; Ronco G
Epidemiol Prev; 2012; 36(6 Suppl 1):78-86. PubMed ID: 23293272
[TBL] [Abstract][Full Text] [Related]
17. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
[TBL] [Abstract][Full Text] [Related]
18. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S
BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073
[TBL] [Abstract][Full Text] [Related]
19. Long-term observational approach in women with histological diagnosis of cervical low-grade squamous intraepithelial lesion: an Italian multicentric retrospective cohort study.
Ciavattini A; Serri M; Di Giuseppe J; Liverani CA; Gardella B; Papiccio M; Delli Carpini G; Morini S; Clemente N; Sopracordevole F
BMJ Open; 2019 Jul; 9(7):e024920. PubMed ID: 31272971
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of high-grade cervical intraepithelial neoplasia during pregnancy: A 10-year experience.
Hong DK; Kim SA; Lim KT; Lee KH; Kim TJ; So KA
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():173-176. PubMed ID: 30933887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
